Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia
Clinical trial NCT00334126 · COMPLETED
Trial details
- NCT number
- NCT00334126
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Enrollment
- 399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.